WATSON 408 (Lisinopril 20 mg)
Pill imprint WATSON 408 has been identified as Lisinopril 20 mg.
Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; migraine prevention; coronary artery disease; heart failure (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 408 (Lisinopril 20 mg)
- 20 mg
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dihydrate dibasic
FD&C Yellow No. 5
|NDC Code||Manufacturer / Repackager|
|63739-0350||McKesson Packaging Services|
|43063-0007||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.